Opleiding tot arts
Universiteit Amsterdam Daar ook schildklieronderzoeker geweest.

Opleiding tot medisch specialist
Academisch Medisch Centrum Amsterdam
Schildklieronderzoeker in Academisch Medisch Centrum Amsterdam
Promotie op de ziekte van Graves (een schildklierziekte en dan met name ook de oogziekte van Graves)

De Boer OJ, Wakelkamp IMMJ, Pals ST, Claessen N, Bos JD, Das PK. Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res 1994; 286 (6): 304-311 

Wakelkamp IMMJ, Gerding MN, Van der Meer JWC, Prummel MF, Wiersinga WM. Both Th1 and Th2 derived cytokines in serum are elevated in Graves’ ophthalmopathy. Clin Exp Immunol 2000; 121 (3): 453-457  

Wakelkamp IMMJ, Gerding MN, Van der Meer JWC, Prummel MF, Wiersinga WM. Smoking   and disease severity are independent determinants of serum adhesion molecule levels in Graves’ophthalmopathy. Clin Exp Immunol 2002; 127 (2):316-320  

Terwee CB, Wakelkamp IMMJ, Tan HS, Dekker FW, Prummel MF, Wiersinga WM. Long-term effects of Graves’ophthalmopathy on health-related quality of life. Eur J of Endocrinol 2002; 146 (6): 751-757  

Wakelkamp IMMJ, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active versus inactive Graves’ ophthalmopathy patients. Clin Endo 2003; 58 (3): 280-287 

Wakelkamp IMMJ, Prummel MF, Wiersinga WM. Serum IL-18 levels are not increased in patients with untreated Graves’ ophthalmopathy. Horm Metab Res 2004; 36 (1): 44-47

Westendorp IC, Tiemessen MA, de Jong M,   Sommers A, Wakelkamp IM, Woersma WG. Moraxella catarrhalis sepsis in a patient with juvenile spinal muscle atrophy.
Neth J Med. 2005 Jun;63(6):227-9. Review.

Wakelkamp IMMJ, Tan H, Saeed P, Schlingemann RO, Verbraak F,. Blank LECM, Prummel MF, Wiersinga WM. Orbital irradiation for Graves’ ophthalmopathy: Is it safe? A long-term follow-up study. Ophthalmology 2004; 111 (8): 1557-1562 

Wakelkamp IMMJ, Baldeschi L, Saeed P, Mourits MP, Prummel MF, Wiersinga WM. Surgical or medical decompression as a first line treatment of optic neuropathy in Graves’ophthalmopathy? A randomized controlled trial. Clin Endocrinol (Oxf). 2005 Sep;63(3):323-8   

Baldeschi L, Lindeboom R, Macandie K, Wakelkamp IMMJ, Wiersinga WM, Hintschich C. The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. Author reply. Am J Ophtalmology 2006 Aug;142(2):352; 353-354   

Baldeschi L, Wakelkamp IM, Lindeboom R, Prummel MF, Wiersinga WM. Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients. Ophthalmology 2006; 113(5):874-878.

Wakelkamp IM, Wiersinga WM. Author's response: medical or surgical decompression of optic neuropathy in Graves' ophthalmopathy: the choice remains unclear. Clinical Endocrinology 2006; 65(3):408.  

Baldeschi L, Lupetti A, Vu P, Wakelkamp IM, Prummel MF, Wiersinga WM. Reactivation of Graves’ orbitopathy after rehabilitive orbital decompression. Ophtalmology. 2007 Jul; 114(7): 1395-402. 

Proefschrift: Graves Ophtalmopathy: in search of better markers and better treatment, april 2005